Cargando…

GSK-3 Inhibitors: Preclinical and Clinical Focus on CNS

Inhibiting glycogen synthase kinase-3 (GSK-3) activity via pharmacological intervention has become an important strategy for treating neurodegenerative and psychiatric disorders. The known GSK-3 inhibitors are of diverse chemotypes and mechanisms of action and include compounds isolated from natural...

Descripción completa

Detalles Bibliográficos
Autores principales: Eldar-Finkelman, Hagit, Martinez, Ana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Research Foundation 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3204427/
https://www.ncbi.nlm.nih.gov/pubmed/22065134
http://dx.doi.org/10.3389/fnmol.2011.00032